| Line Item | 2024-06-30 | Y/Y |
|---|---|---|
| Revenue | $4.6M | +11.2% |
| Cost of Revenue | $3.5M | +44.3% |
| Gross Profit | $1.1M | -21.5% |
| R&D Expense | $3.8M | +0.9% |
| SG&A Expense | $5.3M | -10.2% |
| Pre-tax Income | -$7.7M | +3.4% |
| Income Tax | $7K | -45.8% |
| Net Income | -$7.7M | +3.4% |
| EPS (Basic) | -$1.01 |
| Line Item | 2024-06-30 | Y/Y |
|---|---|---|
| Cash & Equivalents | $6.6M | -26.3% |
| Short-term Investments | $43K | -3.1% |
| Accounts Receivable | $353K | +35.5% |
| Inventory | $1.2M | -23.0% |
| Current Assets | $8.7M | -23.3% |
| Total Assets | $11.8M | -16.2% |
| Current Liabilities | $2.0M | -1.4% |
| Line Item | 2024-06-30 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$7.0M | +4.1% |
| Capital Expenditures | $9K | -94.2% |
| Investing Cash Flow | -$9K | +98.6% |
| Financing Cash Flow | $4.7M | -56.4% |
| Free Cash Flow | -$7.0M | +6.0% |
| +68.9% |
| EPS (Diluted) | -$1.01 | +68.9% |
| Total Liabilities |
| $2.6M |
| +29.8% |
| Stockholders' Equity | $9.2M | -23.9% |